Target intelligence / Profile preview

Hepatitis B Virus Protein Priming Reaction

Molecular classification
Viral Replication, Enzyme Complex, Protein-RNA Interaction
01

Overview

The hepatitis B virus (HBV) protein priming reaction is a unique and essential step in the viral replication cycle. It refers to the initiation of viral DNA synthesis by the HBV polymerase, which uses itself as a primer—a process termed "protein priming." In this mechanism, the initiating nucleotide becomes covalently linked to a specific tyrosine residue on the viral polymerase, enabling reverse transcription of pregenomic RNA (pgRNA) into DNA. The HBV polymerase (also called HP or Pol) is multifunctional and catalyzes reverse transcription. Protein priming begins when HP binds specifically to an RNA signal on pgRNA known as epsilon (ε or Hε), which serves as an obligatory template for initiation. The first deoxynucleotide is covalently attached via a phosphotyrosyl bond to a conserved tyrosine residue in the terminal protein (TP) domain of HP—Y63 in human HBV. This reaction requires both proper recognition of ε and correct folding/conformation of HP, often facilitated by host chaperone proteins. Initiating minus-strand DNA synthesis from pgRNA during viral replication. Ensures that only correctly packaged pgRNA templates are used through strict dependence on ε recognition.

02

Mechanism of action

Inhibition of HBV polymerase activity by disrupting protein-RNA interaction, polymerase conformation, or active site chemistry.

03

Biological functions

Initiation of viral DNA synthesisReverse transcriptionGenome replication
04

Disease associations

InfectionHepatitis BLiver disease
05

Safety considerations

Potential for drug resistanceOff-target effects on host cell polymerases

Beyond the preview

Go deeper on Hepatitis B Virus Protein Priming Reaction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B Virus Protein Priming Reaction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call